M
Manus Bio
Makes nature accessible and affordable for a growing society
About Manus Bio
Manus Bio is a biotechnology startup that operates in the sustainable manufacturing sector. The company leverages advanced cell factory engineering and precision fermentation to transform traditional chemical manufacturing processes. This innovative approach allows Manus Bio to create renewable and scalable routes to materials, chemicals, and ingredients used in various industries, including food, agriculture, and pharmaceuticals.
The company's primary clientele includes businesses in the food, pharmaceutical, and agricultural sectors looking for sustainable and cost-effective alternatives to traditional chemical ingredients. Manus Bio's business model is centered around creating high-performing, sustainable, and affordable ingredients that can be used in a variety of products, from food and wellness goods to bio-agrochemicals and pharmaceuticals.
Manus Bio's revenue is generated through the sale of these bio-engineered ingredients and materials to businesses in their target industries. The company's mission is to translate innovative technologies into sustainable commercial products that are better for both consumers and the planet. They aim to replace traditional chemistry with novel, high-performing biomaterials and therapeutics that improve human health, all while being sustainably sourced and cost-effective.
In summary, Manus Bio is a biotech company that uses advanced cell factory engineering to create sustainable and affordable alternatives to traditional chemical ingredients used in various industries. Their mission is to create a more sustainable future by making nature accessible, affordable, and sustainable.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2011
- Headquarters
- Waltham, United States
- Employees
- 172
- Open positions
- 16
- Dealroom signal
- 92.2/100
- Sector
- Chemicals, Biotechnology, Biomaterials, Synthetic Biology, Spinout, Alternative Protein, Sustainable Development Goals, Micro-Nutrients, Fermentation, Enabler of Alternative Proteins, Climate Tech, DT and LS
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANTOther financing | Mar 2026 | $15M | — | United States Government | ↗ |
| LATE VCOther financing | Jun 2023 | $11M | $375M | Undisclosed | ↗ |
Growth signals
Latest recorded traffic for Manus Bio is 13K monthly website visits, up 42.9% over the last three months. Manus Bio's team grew 4.2% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed8 investors entered at this stage
US National Science Foundation
Rhapsody Venture Partners
Castor Ventures- BVBlue Ivy Ventures
Alumni Ventures
MassChallenge
Bill & Melinda Gates Foundation
United States Government
Series A1 investor entered at this stage
- BBBBGI
Other known investors1 additional known investor
Massachusetts Institute of Technology
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Manus Bio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Manus Bio’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.